Literature DB >> 27275368

Adrenocortical Carcinoma: False Positive in an I-123 Metaiodobenzylguanedine Scan.

Cristina Rodríguez Rey1, Aída Ortega Candil1, Eliseo Vañó Galván2, María Nieves Cabrera Martín1, José Luis Carreras Delgado1.   

Abstract

Entities:  

Year:  2015        PMID： 27275368      PMCID： PMC4870452          DOI： 10.1007/s13139-015-0343-3

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN： 1869-3474


× No keyword cloud information.
  11 in total

1.  Whole-body positron emission tomographic scanning in patients with adrenal cortical carcinoma: comparison with conventional imaging procedures.

Authors:  Mohammed Ahmed; Abdulaziz Al-Sugair; Abdullah Alarifi; Abdulraof Almahfouz; Saif Al-Sobhi
Journal:  Clin Nucl Med       Date:  2003-06       Impact factor: 7.794

Review 2.  PET/CT for adrenal assessment.

Authors:  Michael A Blake; Priyanka Prakash; Carmel G Cronin
Journal:  AJR Am J Roentgenol       Date:  2010-08       Impact factor: 3.959

Review 3.  Adrenal imaging.

Authors:  Michael A Blake; Carmel G Cronin; Giles W Boland
Journal:  AJR Am J Roentgenol       Date:  2010-06       Impact factor: 3.959

4.  False positive metaiodobenzylguanidine scan in a patient with a huge adrenocortical carcinoma.

Authors:  T Rainis; S Ben-Haim; G Dickstein
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

5.  Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma.

Authors:  Gavin C Mackie; Barry L Shulkin; Raul C Ribeiro; Francis P Worden; Paul G Gauger; Rajen J Mody; Len P Connolly; Ghada Kunter; Carlos Rodriguez-Galindo; Jerold W Wallis; Craig A Hurwitz; David E Schteingart
Journal:  J Clin Endocrinol Metab       Date:  2006-04-18       Impact factor: 5.958

6.  Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography.

Authors:  S Leboulleux; C Dromain; G Bonniaud; A Aupérin; B Caillou; J Lumbroso; R Sigal; E Baudin; M Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  2005-12-20       Impact factor: 5.958

7.  Preoperative 18F-FDG uptake is strongly correlated with malignancy, Weiss score, and molecular markers of aggressiveness in adrenal cortical tumors.

Authors:  Lucile Gust; David Taieb; Arnault Beliard; Anne Barlier; Isabelle Morange; Catherine de Micco; Jean-François Henry; Frederic Sebag
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

Review 8.  Role of positron emission tomography/computed tomography in adrenal and neuroendocrine tumors: fluorodeoxyglucose and nonfluorodeoxyglucose tracers.

Authors:  Ka Kit Wong; Mohammad Arabi; Imene Zerizer; Adil Al-Nahhas; Domenico Rubello; Milton D Gross
Journal:  Nucl Med Commun       Date:  2011-09       Impact factor: 1.690

9.  Unusual causes of I-131 metaiodobenzylguanidine uptake in non-neural crest tissue.

Authors:  T Horne; B Glaser; Y Krausz; D Rubinger; K E Britton
Journal:  Clin Nucl Med       Date:  1991-04       Impact factor: 7.794

10.  False-positive diagnosis of adrenal pheochromocytoma on iodine-123-MIBG scan.

Authors:  C Letizia; G De Toma; R Massa; A Corsi; C Caliumi; S Subioli; E D'Erasmo
Journal:  J Endocrinol Invest       Date:  1998-12       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.